FTC closes Adderall XR pay-for-delay probe without taking action
The US Federal Trade Commission has closed an investigation into whether agreements between drugmakers Shire Laboratories, Barr Pharmaceuticals and Impax Laboratories over the ADHD treatment Adderall XR violated antitrust laws, ending...To view the full article, register now.
Already a subscriber? Click here to view full article